Bakır Metabolizması Bozuklukları ve Görüntüleme Bulguları

Menkes JH, Alte M, Steigleder GK, Weakley DR, Sung JH. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics. 1962;29:764-69.

Danks DM, Campbell PE, Stevens BJ, Mayne V, Cartwright E. Menkes’s kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics. 1972;50:188-201.

Lazoff SG, Rybak JJ, Parker BR, Luzzatti L. Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy – a new hereditary syndrome, Birth Defects. Orig Artic Ser. 1975;11:71-74.

Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34:295-509.

Levinson CB, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet.1993;3:7-13.

Chelly J, Tu¨ mer Z, Tonnesen T, Petterson A, et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet.1993;3:14-19.

Mercer JF, Livingston J, Hall B, ET et al. Glover, Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet.1993;3:20-25.

Das S, Levinson B, Vulpe C, Whitney S, Gitschier J, Packman S. Similar splicing mutations of the Menkes/mottled copper-transporting ATPase gene in occipital horn syndrome and the blotchy Mouse. Am J Hum Genet. 1995;56:570-76.

Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5:327-37.

10.Tanzi RE, Petrukhin K, Chernov I et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5: 344-50.

Petrukhin K, Fischer SG, Pirastu M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 1993;5:338-43.

Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease, Biochem. Biophys. Res. Commun. 1993;197:271-77.

Katoh R, Takebayashi Y, Takenoshita S. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas. Ann Thorac Cardiovasc Surg. 2005;11:143-45.

Nakagawa T, Inoue Y, Kodama H. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts. Oncol Rep. 2008;20:265-70.

Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis). Chem Rev. 2006;106:1995-2044.

Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 1962; 29(5):764-79.

[2-67] Kaler SG. Menkes disease. Adv Pediatr. 1994;41:263-304.

Danks DM, Campbell PE, Stevens BJ, Mayne V, Cartwright E. Menkes’s kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics. 1972;50(2):188-201.

Kaler SG. Metabolic and molecular bases of Menkes disease and occipital horn syndrome. Pediatr Dev Pathol Off J Soc. 1998;1(1):85-98.

Kaler SG. (1993). ATP7A-Related Copper Transport Disorders. In: Pagon, R.A., Adam, M.P., Ardinger, H.H., et al. (eds) GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK1413/

Chelly J, Monaco AP. Cloning the Wilson disease gene. Nat Genet. 1993; 5(4):317-18.

Møller LB, Mogensen M, Horn N. Molecular diagnosis of Menkes disease: Genotype-phenotype correlation. Biochimie. 2009; 91(10):1273-77.

Tu¨ mer Z, Moller LB, Horn N. Mutation spectrum of ATP7A, the gene defective in Menkes disease. Adv Exp Med Biol. 1999;448:83-95.

Gu YH, Kodama H, Murata Y, et al. C. Lee, ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome. Am J Med Genet. 2001;99:217-22.

Kodama H, Meguro Y, Abe T. Genetic expression of Menkes disease in cultured astrocytes of the macular Mouse. J Inherited Metab Dis. 1991;14:896-901.

Kodama H. Recent developments in Menkes disease. J Inherited Metab Dis. 1993; 16:791-99.

Gerdes AM, Tønnesen T, Pergament E, et al. Variability in clinical expression of Menkes syndrome. Eur J Pediatr. 1998;148(2):132-35.

Gunn TR, McFarlane S, Phillips LI. Difficulties in the neonatal diagnosis of Menkes’ kinky hair syndrome-trichopoliodystrophy. Clin Pediatr. 1984;23:514-16.

Kaler SG, Holmes CS, Goldstein DS, et al. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008;358:605-14.

Danks, D.M. (1995). Disorders of copper transport. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D.L. (eds) Metabolic and Molecular Bases of Inherited Diseases. 7th ed. McGraw Hill, New York.

Amador E, Domene R, Fuentes C, Carre˜no JC, Enr´ıquez G. Long-term skeletal findings in Menkes disease. Pediatr Radiol. 2010;40(8):1426-29.

Arita JH, Faria EC, Peruchi MM, Lin J, Rodrigues Masruha M, Vilanova LCP. Menkes disease as a differential diagnosis of child abuse. Arq Neuropsiquiatr. 2009;67:507-509.

Cronin H, Fussell JN, Pride H, Bellino P. Menkes syndrome presenting as possible child abuse. Cutis. 2012;90(4):170-72.

Beyens A, van Meensel K, Pottie L, et al. Defining the clinical, molecular and ultrastructural characteristics in Occipital Horn Syndrome. Two new cases and review of the literature. Genes (Basel). 2019;10:528.

Kaler SG, Holmes CS, Goldstein DS, et al. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008;358(6):605-14.

Akinseye ON, Yazdani R, Tornow KA, Reeder KN, Clarke RL, Pfeifer CM. Imaging findings of Menkes disease, a radiographic mimic of abusive trauma. Radiol Case Rep. 2019;14(8):993-96.

Sherwood G, Sarkar B, Kortsak AS. Copper histidinate therapy in Menkes’ disease prevention of progressive neurodegeneration. J Inherited Metab Dis. 1989;12(2):393-96.

Sarkar B, Lingertat-Walsh K, Clarke JT. Copper–histidine therapy for Menkes disease. J Pediatr.1993;123:828-30.

Tu¨ mer Z, Horn N, Tonnesen T, Christodoulou J, Clarke JT, Sarkar B. Early copper–histidine treatment for Menkes disease. Nat Genet.1996;12:11-13.

Kaler SG, Holmes CS, Goldstein DS, et al. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008;358:605-14.

Gu YH, Kodama H, Du SL, Gu QJ, Sun HJ, Ushijima H. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson’s disease. Clin Genet. 2003;64:479-84.

Gromadzka G, Schmidt HH, Genschel J, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease. Clin Genet. 2005;68:524-32.

Nartey NO, Frei LV, Cherian MG. Hepatic copper and metallothionein distribution in Wilson’s disease (hepatolenticular degeneration). Lab Invest.1987;57.397-401.

EASL Clinical Practice guidelines: Wilson’s disease (2012) J Hepatol 56:671-85.

Kodama, H. (1996). Genetic disorders of copper metabolism, in Toxicology of metals. Lewis Publishers, New York. pp. 371-85.

Zhuang XH, Mo Y, Jiang XY, Chen SM. Analysis of renal impairment in children with Wilson’s disease. World J Pediatr. 2008;4;102-105.

Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson’s disease. Methods in pathology. Am J Clin Pathol. 1994;102(4):443-46.

Fischer RT, Soltys KA, Squires RH, Jaffe R, Mazariegos GV, Shneider BL. Prognostic scoring indices in Wilson disease: A case series and cautionary tale. J Pediatr Gastroenterol Nutr. 2011;52(4):466-69.

Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation forWilson’s disease: Indications and outcome. Hepatol Baltim Md. 1994;19(3):583-87.

Medici V, Mirante VG, Fassati LR, et al. Liver transplantation forWilson’s disease: The burden of neurological and psychiatric disorders, Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2005;11(9):1056-63.

Sevmis S, Karakayali H, Aliosmanoglu I, et al. Liver transplantation for Wilson’s disease. Transplant Proc. 2008;40(1):228-30.

Weiss KH, Thurik F, Gotthardt DN, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2013;11(8):1028-35

Fox AN, Schilsky M. Once daily trientine for maintenance therapy of Wilson disease. Am J Gastroenterol. 2008;103(2):494-95.

Ala A, Aliu E, Schilsky ML. Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease. Dig Dis Sci. 2015; 60(5):1433-39.

Weiss KH, Gotthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011;140(4):1189-98.

Ranucci G, Dato FD, Spagnuolo MI, Vajro P, Iorio R. Zinc monotherapy is effective in Wilson’s disease patients with mild liver disease diagnosed in childhood: A retrospective study. Orphanet J Rare Dis. 2014;9(1):41.

Horvath J, Beris P, Giostra E, Martin PY, Burkhard PR. Zinc-induced copper deficiency in Wilson disease. J Neurol Neurosurg Psychiatry. 2010;81(12):1410-11.

Cortese A, Zangaglia R, Lozza A, Piccolo G, Pacchetti C. Copper deficiency in Wilson’s disease: Peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment. Mov Disord Off J Mov Disord Soc. 2011;26(7):1361-62.

Foubert-Samie A, Kazadi A, Rouanet M, et al. Axonal sensory motor neuropathy in copper-deficient Wilson’s disease. Muscle Nerve. 2009; 40(2):294-96.

Yoshitoshi EY, Takada Y, Oike F, et al. Long-term outcomes for 32 cases of Wilson’s disease after living-donor liver transplantation. Transplantation. 2009;87(2):261-67.

Arnon R, Annunziato R, Schilsky M, et al. Liver transplantation for children with Wilson disease: Comparison of outcomes between children and adults. Clin Transplant. 2011;25(1):E52–E60.

Yu XE, Gao S, Yang RM, Han YZ. MR Imaging of the Brain in Neurologic Wilson Disease. AJNR. Am J Neuroradiol. 2019;40(1):178-83.